Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.
Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, Facklam RR, Jorgensen JH, Besser J, Zell ER, Schuchat A, Whitney CG; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Kyaw MH, et al. Among authors: jorgensen jh. N Engl J Med. 2006 Apr 6;354(14):1455-63. doi: 10.1056/NEJMoa051642. N Engl J Med. 2006. PMID: 16598044 Free article.
Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States.
Beall B, McEllistrem MC, Gertz RE Jr, Boxrud DJ, Besser JM, Harrison LH, Jorgensen JH, Whitney CG; Active Bacterial Core Surveillance/Emerging Infections Program Network. Beall B, et al. Among authors: jorgensen jh. J Infect Dis. 2002 Jul 1;186(1):118-22. doi: 10.1086/341072. Epub 2002 Jun 14. J Infect Dis. 2002. PMID: 12089672
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.
Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Whitney CG, et al. Among authors: jorgensen jh. N Engl J Med. 2003 May 1;348(18):1737-46. doi: 10.1056/NEJMoa022823. N Engl J Med. 2003. PMID: 12724479 Free article.
Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin.
Schrag SJ, McGee L, Whitney CG, Beall B, Craig AS, Choate ME, Jorgensen JH, Facklam RR, Klugman KP; Active Bacterial Core Surveillance Team. Schrag SJ, et al. Among authors: jorgensen jh. Antimicrob Agents Chemother. 2004 Aug;48(8):3016-23. doi: 10.1128/AAC.48.8.3016-3023.2004. Antimicrob Agents Chemother. 2004. PMID: 15273115 Free PMC article.
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.
Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, Nyquist AC, Gershman KA, Vazquez M, Bennett NM, Reingold A, Thomas A, Glode MP, Zell ER, Jorgensen JH, Beall B, Schuchat A. Whitney CG, et al. Among authors: jorgensen jh. Lancet. 2006 Oct 28;368(9546):1495-502. doi: 10.1016/S0140-6736(06)69637-2. Lancet. 2006. PMID: 17071283
Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.
Moore MR, Gertz RE Jr, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH, Hadler JL, Bennett NM, Thomas AR, McGee L, Pilishvili T, Brueggemann AB, Whitney CG, Jorgensen JH, Beall B. Moore MR, et al. Among authors: jorgensen jh. J Infect Dis. 2008 Apr 1;197(7):1016-27. doi: 10.1086/528996. J Infect Dis. 2008. PMID: 18419539
PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007.
Carvalho Mda G, Pimenta FC, Gertz RE Jr, Joshi HH, Trujillo AA, Keys LE, Findley J, Moura IS, Park IH, Hollingshead SK, Pilishvili T, Whitney CG, Nahm MH, Beall BW; Active Bacterial Core Surveillance Team. Carvalho Mda G, et al. J Clin Microbiol. 2009 Mar;47(3):554-9. doi: 10.1128/JCM.01919-08. Epub 2008 Dec 30. J Clin Microbiol. 2009. PMID: 19116353 Free PMC article.
Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.
Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS, Farley MM, Jorgensen JH, Lexau CA, Petit S, Reingold A, Schaffner W, Thomas A, Whitney CG, Harrison LH. Hsu HE, et al. Among authors: jorgensen jh. N Engl J Med. 2009 Jan 15;360(3):244-56. doi: 10.1056/NEJMoa0800836. N Engl J Med. 2009. PMID: 19144940 Free PMC article.
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.
Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, Petit S, Zansky SM, Harrison LH, Reingold A, Miller L, Scherzinger K, Thomas A, Farley MM, Zell ER, Taylor TH Jr, Pondo T, Rodgers L, McGee L, Beall B, Jorgensen JH, Whitney CG. Moore MR, et al. Among authors: jorgensen jh. Lancet Infect Dis. 2015 Mar;15(3):301-9. doi: 10.1016/S1473-3099(14)71081-3. Epub 2015 Feb 3. Lancet Infect Dis. 2015. PMID: 25656600 Free PMC article.
259 results